BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1621981)

  • 21. Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro.
    Bitzan M; Richardson S; Huang C; Boyd B; Petric M; Karmali MA
    Infect Immun; 1994 Aug; 62(8):3337-47. PubMed ID: 8039905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
    Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
    Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1.
    Meisen I; Friedrich AW; Karch H; Witting U; Peter-Katalinić J; Müthing J
    Rapid Commun Mass Spectrom; 2005; 19(24):3659-65. PubMed ID: 16285017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the carbohydrate-binding specificity of pig edema toxin.
    Cummings MD; Ling H; Armstrong GD; Brunton JL; Read RJ
    Biochemistry; 1998 Feb; 37(7):1789-99. PubMed ID: 9485304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro : A new assay to define factors affecting glycosphingolipid receptor activity.
    Nutikka A; Lingwood C
    Glycoconj J; 2004; 20(1):33-8. PubMed ID: 14973368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Globotetraosylceramide is recognized by the pig edema disease toxin.
    DeGrandis S; Law H; Brunton J; Gyles C; Lingwood CA
    J Biol Chem; 1989 Jul; 264(21):12520-5. PubMed ID: 2663859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
    Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
    Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
    Lingwood CA; Yiu SK
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
    Devenish J; Gyles C; LaMarre J
    Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid modulation of glycolipid receptor function. Availability of Gal(alpha 1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids.
    Boyd B; Magnusson G; Zhiuyan Z; Lingwood CA
    Eur J Biochem; 1994 Aug; 223(3):873-8. PubMed ID: 8055965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verotoxin-binding in human renal sections.
    Lingwood CA
    Nephron; 1994; 66(1):21-8. PubMed ID: 8107950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
    J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of protein-glycolipid recognition at the membrane bilayer.
    Evans SV; Roger MacKenzie C
    J Mol Recognit; 1999; 12(3):155-68. PubMed ID: 10398406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
    Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
    J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verotoxins and their glycolipid receptors.
    Lingwood CA
    Adv Lipid Res; 1993; 25():189-211. PubMed ID: 8368148
    [No Abstract]   [Full Text] [Related]  

  • 36. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
    Cooling LL; Walker KE; Gille T; Koerner TA
    Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3.
    Newburg DS; Ashkenazi S; Cleary TG
    J Infect Dis; 1992 Oct; 166(4):832-6. PubMed ID: 1527419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli.
    Brown JE; Echeverria P; Lindberg AA
    Rev Infect Dis; 1991; 13 Suppl 4():S298-303. PubMed ID: 2047653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.
    Lingwood CA; Law H; Richardson S; Petric M; Brunton JL; De Grandis S; Karmali M
    J Biol Chem; 1987 Jun; 262(18):8834-9. PubMed ID: 3298243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of Glycolipid Ligands of Carbohydrate-Binding Proteins Directly on Thin Layer Chromatograms.
    Magnani JL
    Methods Mol Biol; 2018; 1804():419-427. PubMed ID: 29926422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.